Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Boostrix Systems Biology Study in Healthy Adults
NCT02555540Phase 4Completed
- Sponsor
- Ghent University Hospital
- Start
- Aug 2015
- Primary completion
- Dec 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of acellular pertussis vaccine in pertussis, diphtheria, Tetanus, sponsored by Ghent University Hospital. Started Aug 2015; status: completed.
02
Drugs
acellular pertussis vaccine
03
Conditions
pertussisdiphtheriaTetanus
Beyond the preview
Go deeper on NCT02555540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02555540.